http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0016092-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
filingDate 2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce16977e86020434c6159292bd4040ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e85339b230efdebbb9cfe04489bf526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5166ecc37428f215f05170256cc7f04f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b6cae01493b8bdba56d4f985d64ed4
publicationDate 2002-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0016092-A
titleOfInvention Compound, use of a compound kit for hormonal contraception in a male, and method of treatment
abstract "COMPOUND, USE OF A COMPOUND KIT FOR HORMONAL CONTRACEPTION IN A MALE, AND, TREATMENT METHOD". The invention described relates to the unexpected verification of unpublished steroids that are characterized by a 14 <225> -15 <225> -cyclopropane ring and a hydroxymethyl group at 17 <244>. These steroids according to the invention have been found to have an androgenic activity in common. They can be used for the preparation of an agent for male contraception, and also for the preparation of a drug for the treatment of androgen insufficiency.
priorityDate 1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482

Total number of triples: 15.